Issues related to corporate tax policy. Issues related to treatment challenges for cardiovascular disease. Issues related to implementation of drug pricing and reimbursement for prescription drugs provision in Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D drug rebates.
TAX - Taxation/Internal Revenue Code BUD - Budget/Appropriations MMM - Medicare/Medicaid
1 - SENATE 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
COREY MALMGREN JONATHON JONES JONATHON JONES JOHN MICHAEL GONZALEZ COREY MALMGREN